These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9950644)

  • 1. Pharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in rats.
    Hanada E; Ohtani H; Kotaki H; Sawada Y; Sato H; Iga T
    J Pharm Sci; 1999 Feb; 88(2):234-40. PubMed ID: 9950644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
    Hanada E; Ohtani H; Hirota M; Uemura N; Nakaya H; Kotaki H; Sato H; Yamada Y; Iga T
    J Pharm Pharmacol; 2003 Jul; 55(7):995-1002. PubMed ID: 12906757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interaction between mosapride and erythromycin without electrocardiographic changes.
    Katoh T; Saitoh H; Ohno N; Tateno M; Nakamura T; Dendo I; Kobayashi S; Nagasawa K
    Jpn Heart J; 2003 Mar; 44(2):225-34. PubMed ID: 12718484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of disopyramide and erythromycin on ventricular repolarization in dogs with complete atrioventricular block.
    Watanabe I; Okumura Y; Nagashima K; Kofune M; Ohkubo K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(6):393-7. PubMed ID: 22188715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
    Echizen H; Kawasaki H; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1425-31. PubMed ID: 8450476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations.
    Brannan MD; Reidenberg P; Radwanski E; Shneyer L; Lin CC; Cayen MN; Affrime MB
    Clin Pharmacol Ther; 1995 Sep; 58(3):269-78. PubMed ID: 7554700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction.
    Dakhel Y; Jamali F
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):24-9. PubMed ID: 16466760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L; Grais IM; Passman RS
    Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of clinically relevant interaction between desloratadine and erythromycin.
    Banfield C; Hunt T; Reyderman L; Statkevich P; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():29-35. PubMed ID: 12169044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.
    Ohtani H; Taninaka C; Hanada E; Kotaki H; Sato H; Sawada Y; Iga T
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2630-7. PubMed ID: 10991836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats.
    Ohtani H; Hanada E; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Sep; 19(9):1189-96. PubMed ID: 8889039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
    Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
    Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypokalaemia on arrhythmogenic risk of quinidine in rats.
    Hirota M; Ohtani H; Hanada E; Kotaki H; Sawada Y; Iga T
    Life Sci; 1998; 62(24):2159-69. PubMed ID: 9627074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.
    Honig PK; Woosley RL; Zamani K; Conner DP; Cantilena LR
    Clin Pharmacol Ther; 1992 Sep; 52(3):231-8. PubMed ID: 1526078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.